A few days ago, the Ohio Department of Health stated that less than 10% of Ohioans have come forward to receive the new COVID-19 vaccine. In figures, this would correspond to 1.1 million of the population (9.3%) residing in this state. If we make the comparison, the improvement is significant thanks to the use of vaccines.
How Have the Vaccines Influenced the Hospitalization Data?
Hospitalizations due to the virus are down; about 450 per week, according to the Ohio Department of Health (ODH). Its director, Dr. Bruce Vanderhoff, said of this situation, “Vaccines help us all.” In 2021, according to Vanderhoff, Ohio had a record of 2,000 to 3,000 hospitalizations per week due to COVID-19, which progressively decreased to 600 last year. Still, vaccine production requires a number of procedures to be carried out. One of them is tissue homogenization, through which intercellular materials such as DNA, RNA and proteins are released.
The Importance of Ventilation in Enclosed Spaces
On the other hand, COVID-19 can spread in poorly ventilated indoor spaces. Detecting its presence in the air of these environments is possible by using an air sampler. However, it must be able to collect a large volume of air to obtain a reliable result since, being a virus, its concentration level is low.
Increase in the Number of Vaccinated Seniors
No doubt, the decline in COVID-19 hospitalizations represents a favorable phenomenon in Ohio’s healthcare system. However, Vanderhoff is concerned about the low number of people who have received the updated vaccine to counteract the effects of this disease, considering that it has been available since September. Another point in favor of this statistic is the growth in the percentage of older adults over 65 years who received the vaccine, being 29% specifically. “There remains a lot of room for improvement, and let’s not forget that this virus is still causing several dozen deaths every week in Ohio,” Vanderhoff said.
The New Vaccine Provides Greater Protection Against COVID
All those who receive the new updated vaccine will be helped to boost their immune system so that their body will not experience a severe form of the disease. It will also lower the chances of developing long-standing COVID-19. Those who experience long-term COVID-19 can have a wide variety of symptoms that can last for weeks, months, or even years.
Aside from COVID-19, Ohio’s healthcare system is targeting other diseases that have not been prevalent and have been reappearing in recent years. Regarding this, Vanderhoff points out, “This year, we have seen an increase in a variety of other respiratory illnesses including well-known bacterial pathogens we haven’t seen much of the last few years”.
Some parts of Ohio have been reporting cases of bacterial pneumonia, which is caused by the bacterium mycoplasma pneumonia, a bacterial pathogen, with young people being most affected. “This bacterium is well known to physicians, but around the world, we are seeing this organism bounce back this year after not having played a major role in recent winters,” Vanderhoff said.
He also points out that since this is an outbreak, most of the pneumonia cases are not reportable to ODH and that represents a sign that there has been an unusual number of cases of the same disease, at the same time and in the same area. And while Ohio has a vaccine against pneumonia, it provides immunity against another type of bacteria: Streptococcus pneumonia.